StepStone Group LP - ENTRADA THERAPEUTICS INC ownership

ENTRADA THERAPEUTICS INC's ticker is and the CUSIP is 29384C108. A total of 48 filers reported holding ENTRADA THERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is - and the average weighting 1.0%.

Quarter-by-quarter ownership
StepStone Group LP ownership history of ENTRADA THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$12,028,177
+4.4%
761,2770.0%2.68%
+25.7%
Q2 2023$11,525,734
+4.4%
761,2770.0%2.13%
+3.9%
Q1 2023$11,038,517
+7.2%
761,2770.0%2.05%
+52.7%
Q4 2022$10,292,465
-14.2%
761,2770.0%1.34%
-21.3%
Q3 2022$11,998,000
+55.1%
761,277
+19.9%
1.71%
+106.3%
Q2 2022$7,734,000
+8.2%
634,959
-16.6%
0.83%
+55.2%
Q1 2022$7,148,000
-45.2%
761,2770.0%0.53%
-28.3%
Q4 2021$13,033,000761,2770.74%
Other shareholders
ENTRADA THERAPEUTICS INC shareholders Q4 2022
NameSharesValueWeighting ↓
72 Investment Holdings, LLC 509,023$7,706,60860.04%
MPM ASSET MANAGEMENT LLC 4,425,784$67,006,37032.86%
5AM Venture Management, LLC 4,408,379$66,742,85816.63%
StepStone Group LP 761,277$11,525,7342.13%
TCG Crossover Management, LLC 584,955$8,856,2191.45%
Redmile Group, LLC 1,311,572$19,857,2000.76%
Nan Fung Group Holdings Ltd 49,082$743,1010.48%
Baker Brothers Advisors 4,865,819$73,668,5000.43%
Corton Capital Inc. 18,067$273,5340.13%
MOORE CAPITAL MANAGEMENT, LP 105,000$1,589,7000.03%
View complete list of ENTRADA THERAPEUTICS INC shareholders